Signaling pathways
-
BA5110 LubabegronSummary: Lubabegron is a potent beta-adrenergic receptor modulator. - BA5111 L-765314Summary: L-765314 is a potent, selective antagonist.
-
BA5112 OlodaterolSummary: Olodaterol (BI1744) is a selective - BA5113 BufuralolSummary: Bufuralol (Ro3-4787) is a potent, non-selective, orally active beta-adrenoceptor antagonist with partial agonist activity.
- BA5115 LevonordefrinSummary: Levonordefrin is a common alternative to levylephrine as a vasoconstrictor in dental local anesthetics and is typically used in concentrations up to five times higher.
- BA5116 BatefenterolSummary: Batefenterol (GSK961081; TD-5959) is a new receptor antagonist and -adrenergic receptor agonist; on hM2.
- BA5117 PractololSummary: Practolol is a potent and selective adrenergic receptor antagonist.
-
BA5118 PropafenoneSummary: Propafenone (SA-79) is a sodium channel blocker with antiarrhythmic properties. -
BA5120 TulobuterolSummary: Tulobuterol (C-78freebase) is a long-acting beta-adrenergic receptor agonist that reduces the frequency of exacerbations in chronic obstructive pulmonary disease and bronchial asthma. - BA5121 DenopamineSummary: Denopamine ((R)-(-)-Denopamine) is a potent, orally active, selective beta1-adrenergic agonist.